Aegis Science

Nashville, United States Founded: 1986 • Age: 40 yrs Acquired By Abry
Drug testing and clinical laboratory services are provided.
Annual revenue - Latest available
Total funding - 5 rounds
Employees 1142 Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Aegis Science

Aegis Science is a company based in Nashville (United States) founded in 1986 was acquired by Abry in February 2014. The company has 1,142 employees as of December 31, 2022. Aegis Science has completed 2 acquisitions, including Ameritox and Diagnovus.

  • Headquarter Nashville, United States
  • Employees 1142 as on 31 Dec, 2022
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Not available
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $6.6 M (USD), Grant

    Aug 13, 2020

  • Investors
    HHS

    & 3 more

  • Employee Count
    1142

    as on Dec 31, 2022

  • Investments & Acquisitions
    Ameritox

    & 1 more

  • Acquired by
    Abry

    & 1 more

    (Feb 24, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Aegis Science

Headcount 1000-5000
Employee Profiles 73
Employee Profiles
People
Hope Randle
Clinical Pharmacist
People
Joel Galanter
Chief Legal Officer & General Counsel
People
Mike Ziegler
Chief Commercial Officer
People
Xoe Thacker
Healthcare Analyst - Revenue Cycle

Unlock access to complete

Funding Insights of Aegis Science

Investors in Aegis Science

Aegis Science has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Abry Partners and Crescent Capital BDC.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Metalmark Capital is focused on growth equity investments in middle-market companies.
Locked Locked Locked
Abry Partners is engaged in middle market private equity investments.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Premium access

Investor details for Aegis Science

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Aegis Science

Aegis Science has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Ameritox and Diagnovus.

Investments
Premium access

Investment portfolio details for Aegis Science

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Molecular diagnostics for rare diseases are provided by Diagnovus.
Locked Locked 2011 Locked
Pain medication monitoring solutions are provided for US clinicians.
Locked Locked 1996 Locked
Premium access

Complete acquisition details for Aegis Science

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Aegis Science

Premium access

Detailed financials for Aegis Science

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Aegis Science Comparisons

Aegis Science Primary company
Description
Drug testing and clinical laboratory services are provided.
Location
Nashville, United States
Founded Year
1986
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
1,142
As of 2022
Premium access

Peer comparison for Aegis Science

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Aegis Science

Premium access

Detailed competitors of Aegis Science

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Aegis Science

Premium access

Complete news archive for Aegis Science

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aegis Science

Aegis Science was founded in 1986 and raised its 1st funding round 22 years after it was founded.

Aegis Science is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.

As of Dec 31, 2022, the latest employee count at Aegis Science is 1,142.

Provider of drug testing and clinical laboratory services. It offers testing solutions for pain management, mental illness, substance use disorder, and sports. Services include adherence monitoring, clinical blood testing, and infectious disease testing. The company also provides analytical tools to track novel psychoactive substances. It maintains CLIA certification and other relevant accreditations, and offers clinical support and seamless EMR connectivity. Testing is available in oral fluid and urine.

Aegis Science has made 2 acquisitions, including Ameritox, and Diagnovus.

Aegis Science has 4 investors. Key investors include HHS, Abry Partners, Crescent Capital BDC, and Metalmark Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available